Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3131-32-6
2. Antazoline Methanesulfonate
3. Analergin
4. 2-phenylbenzylaminomethylimidazoline Methanesulfonate
5. Antistine Methyl Sulfonate
6. Phenazoline Methanesulfonate
7. Antazoline Methane Sulphonate
8. Ku470j7ty6
9. Nsc-7438
10. N-phenyl-n-benzylaminomethyl Imidazoline Methyl Sulfonate
11. N-benzyl-n-(4,5-dihydro-1h-imidazol-2-ylmethyl)aniline;methanesulfonic Acid
12. N-benzyl-n-((4,5-dihydro-1h-imidazol-2-yl)methyl)aniline Methanesulfonate
13. Unii-ku470j7ty6
14. Nsc 7438
15. Einecs 221-523-2
16. 2-n-benzyl Anilino Methyl Imidazoline
17. Antazoline Mesilate
18. Schembl5600741
19. Antazoline Methansulfonate
20. Dtxsid70953352
21. Nsc7438
22. Antazoline Methanesulphonate
23. 2-imidazoline, Monomethanesulfonate
24. Antazoline Mesilate [mart.]
25. 2-imidazoline, 2-((n-benzylanilino)methyl)-, Monomethanesulfonate
26. Antazoline Mesilate [who-dd]
27. 2-imidazoline, 2-((benzylanilino)methyl)-, Monomethanesulfonate
28. 1h-imidazole-2-methanamine, 4,5-dihydro-n-phenyl-n-(phenylmethyl)-, Monomethanesulfonate
29. 4,5-dihydro-n-phenyl-n-(phenylmethyl)-1h-imidazole-2-methanamine Monomethanesulfonate
30. Ds-013560
31. Wln: T5m Cn Butj B1nr&1r &osw1
32. A-8140
33. Q27282440
34. N-benzyl-n-(2-imidazolin-2-ylmethyl)aniline Methanesulfonate
35. N-benzyl-n-(2-imidazolin-2-ylmethyl)aniline Methanesulphonate
36. 1h-imidazole-2-methanamine,5-dihydro-n-phenyl-n-(phenylmethyl)-, Monomethanesulfonate
37. Methanesulfonic Acid--n-benzyl-n-[(4,5-dihydro-1h-imidazol-2-yl)methyl]aniline (1/1)
38. 25138-84-5
| Molecular Weight | 361.5 g/mol |
|---|---|
| Molecular Formula | C18H23N3O3S |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | 361.14601278 g/mol |
| Monoisotopic Mass | 361.14601278 g/mol |
| Topological Polar Surface Area | 90.4 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 407 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Antazoline Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Antazoline Mesylate, including repackagers and relabelers. The FDA regulates Antazoline Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Antazoline Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Antazoline Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Antazoline Mesylate supplier is an individual or a company that provides Antazoline Mesylate active pharmaceutical ingredient (API) or Antazoline Mesylate finished formulations upon request. The Antazoline Mesylate suppliers may include Antazoline Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Antazoline Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Antazoline Mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Antazoline Mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Antazoline Mesylate GMP manufacturer or Antazoline Mesylate GMP API supplier for your needs.
A Antazoline Mesylate CoA (Certificate of Analysis) is a formal document that attests to Antazoline Mesylate's compliance with Antazoline Mesylate specifications and serves as a tool for batch-level quality control.
Antazoline Mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Antazoline Mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Antazoline Mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Antazoline Mesylate EP), Antazoline Mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Antazoline Mesylate USP).
LOOKING FOR A SUPPLIER?
